"Leukotriene E4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. (From Dictionary of Prostaglandins and Related Compounds, 1990)
| Descriptor ID |
D017999
|
| MeSH Number(s) |
D10.251.355.255.100.450.855.470 D10.251.355.310.166.887.855.470 D23.469.050.175.450.725.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Leukotriene E4".
Below are MeSH descriptors whose meaning is more specific than "Leukotriene E4".
This graph shows the total number of publications written about "Leukotriene E4" by people in this website by year, and whether "Leukotriene E4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukotriene E4" by people in Profiles.
-
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers. Cancer Prev Res (Phila). 2013 Jul; 6(7):646-55.
-
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. COPD. 2011 Feb; 8(1):21-9.